Posted by
Paul Fletcher
0 Comments
China and India dominate global pharmaceutical manufacturing, but their FDA compliance and supply chain risks differ sharply. India leads in regulatory reliability, while China dominates in scale and APIs - yet both face serious challenges.
read more